Two new potential therapeutic targets for the treatment of pulmonary arterial hypertension, a deadly disease marked by high blood pressure in the lungs, have been identified by researchers at the University of Illinois at ...
Sep 8, 2014
0
0
Oxidized lipids are known to play a key role in inflaming blood vessels and hardening arteries, which causes diseases like atherosclerosis. A new study at UCLA demonstrates that they may also contribute to pulmonary hypertension, ...
Aug 27, 2014
0
0
The American College of Chest Physicians (CHEST) announced today the Online First publication of Pharmacological Therapy for Pulmonary Arterial Hypertension in Adults: CHEST Guideline in the journal Chest. Pulmonary arterial ...
Jun 17, 2014
0
0
The American Thoracic Society has developed clinical practice guidelines to help clinicians identify and manage patients with sickle cell disease who are at increased risk for mortality from pulmonary hypertension.
Mar 15, 2014
0
0
The development of new, more effective vasodilators to treat pulmonary arterial hypertension (PAH) has been hampered because of their systemic toxicity and adverse side effects. An international team of investigators seeking ...
Jan 7, 2014
0
0
(Medical Xpress)—The world's leading voices in the fight against pulmonary hypertension have compiled a special publication detailing the breakthrough research into the causes of this debilitating vascular disease.
Jan 6, 2014
0
0
(HealthDay)—Patients with systemic sclerosis have elevated levels of CXCL4, which predicts disease risk and progression, according to a study published online Dec. 18 in the New England Journal of Medicine.
Dec 19, 2013
0
0
Multiple types of cells are needed for patients to recover from surgery or to restore life to tissues that have lost circulation. University of Georgia researchers have identified how the cells involved in the final stage ...
Dec 6, 2013
0
1
A team of UW-Madison researchers has discovered important biomechanical changes in human arteries that could increase understanding of how pulmonary hypertension leads to heart failure.
Nov 11, 2013
0
0
(HealthDay)—Opsumit (macitentan) has been approved by the U.S. Food and Drug Administration to treat adults with pulmonary arterial hypertension, a debilitating disease characterized by high blood pressure in the lung arteries.
Oct 23, 2013
0
0
